Medication info
Atorva 20 mg Tablet (Atorvastatin Calcium Trihydrate)

Atorva 20 mg Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201310004 · Approved 2013.11.01 · Insurance code 652903400

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the drug at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater LDL-cholesterol reduction may start with 20 mg or 40 mg once daily (only when an LDL-cholesterol reduction of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL-cholesterol, LDL-cholesterol levels are recommended for use at treatment initiation and when evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular reconstruction
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hyperlipidemia
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke, as well as the risk of heart-related issues such as vascular reconstruction or angina. It is also effective for diabetes patients or those with multiple risk factors. Additionally, it improves cholesterol and triglyceride levels in patients with primary hypercholesterolemia and dyslipidemia, and aids in increasing HDL cholesterol. This medication is used as an adjunct treatment to lower cholesterol levels in pediatric patients with familial hypercholesterolemia. Overall, it is used to improve heart and vascular health.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the drug at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater LDL-cholesterol reduction may start with 20 mg or 40 mg once daily (only when an LDL-cholesterol reduction of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL-cholesterol, LDL-cholesterol levels are recommended for use at treatment initiation and when evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication should be discontinued immediately and a doctor consulted if any unusual muscle symptoms occur. Particular caution is needed if severe muscle pain, weakness, or cramps develop. This medication should not be used in patients with poor liver function or liver diseases, and regular liver function tests should be conducted. If symptoms of hepatitis or jaundice occur, medical personnel should be informed immediately. This medication should not be taken by women who are pregnant or may become pregnant, and by breastfeeding women. Women of childbearing potential should use appropriate contraception while taking this medication. This medication is not to be given to children under 10 years old or patients with specific genetic lactose intolerance disorders. As this medication has many drug interactions, it is crucial to consult with a doctor or pharmacist when taking it with certain antibiotics, antifungal agents, HIV treatments, and some antihypertensive medications. Elderly patients or those with reduced kidney function should be observed more closely due to an increased risk of muscle-related side effects while taking this medication. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, the doctor should be informed immediately, and a blood test should be conducted. If significantly elevated serum creatine kinase levels are found, the medication should be discontinued. Taking this medication with grapefruit juice may increase blood concentration, increasing the risk of side effects, so it is advisable to avoid grapefruit juice. It is preferable to refrain from alcohol consumption during treatment and to undergo periodic liver function tests for liver health.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngalgia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory impairment
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • urinary leukocyte positive
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial dizziness
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgent urination
  • abnormal ejaculation
  • uterine bleeding
  • pigmented urine
  • hypoglycemia
  • increased appetite
  • vascular neurogenic edema
  • chest pain
  • angina pectoris
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • dysgeusia
  • ageusia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 to 30 degrees Celsius room temperature. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.